Moreover, AAV-sh-Elk1 treatment depressed IL-17 and IL-6 expression in lung tissues of ARDS rats, which was negated by AAV-sh-Fcgr2b treatment (Fig. 6E). The gene discussed is ELK1; the disease is acute respiratory distress syndrome.